# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Chronic bronchitis

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 19 results.
RejuvenAir® System Trial for COPD With Chronic Bronchitis
Status: Recruiting
Last Changed: Nov 05, 2020
First Received: Mar 28, 2019
Disease(s): Chronic Bronchitis
Intervention(s): RejuvenAir System, Sham Control Procedure
Locations: El Camino Hospital, Mountain View, California, United States
University of California, Davis Medical Center, Sacramento, California, United States
Sarasota Memorial Hospital, Sarasota, Florida, United States
Norton Pulmonary Specialists, Louisville, Kentucky, United States
Louisiana State University Medical Center, Shreveport, Louisiana, United States
... and 12 other locations.
VX-770 for the Treatment of Chronic Bronchitis
Status: Recruiting
Last Changed: Jan 30, 2020
First Received: Aug 16, 2017
Disease(s): Chronic Bronchitis
Intervention(s): Ivacaftor (VX-770)
Locations: University of Alabama at Birmingham, Birmingham, Alabama, United States
A Study to Assess the Safety, Tolerability, and Efficacy of ION-827359 in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis (CB)
Status: Recruiting
Last Changed: Nov 23, 2020
First Received: Jun 22, 2020
Disease(s): Chronic Bronchitis, Chronic Obstructive Pulmonary Disease
Intervention(s): ION-827359, Placebo
Locations: Queen Anne Street Medical Centre, Heart Lung Center, London, United Kingdom
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis
Status: Not yet recruiting
Last Changed: Nov 16, 2020
First Received: Nov 16, 2020
Disease(s): Chronic Obstructive Pulmonary Disease (COPD), Chronic Bronchitis
Intervention(s): MEDI3506, Placebo
Locations: Research Site, Newport Beach, California, United States
Research Site, Newark, Delaware, United States
Research Site, Celebration, Florida, United States
Research Site, Clearwater, Florida, United States
Research Site, Winter Park, Florida, United States
... and 49 other locations.
Metered Cryospray for the Treatment of Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Status: Recruiting
Last Changed: Aug 24, 2020
First Received: Mar 27, 2019
Disease(s): COPD, Chronic Bronchitis
Intervention(s): RejuvenAir System, Sham
Locations: University Medical Center Groningen, Groningen, Netherlands
The Royal Brompton Hospital, London, United Kingdom
A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER)
Status: Not yet recruiting
Last Changed: Nov 19, 2020
First Received: Nov 19, 2020
Disease(s): Chronic Obstructive Pulmonary Disease
Intervention(s): Experimental: CHF6001 1600µg, Experimental: CHF6001 3200µg, Placebo
HHHFA in COPD Patients, With Chronic Bronchitis
Status: Not yet recruiting
Last Changed: Oct 19, 2020
First Received: May 22, 2019
Disease(s): Pulmonary Disease, Chronic Obstructive
Intervention(s): HHHFA Device, Spirometry, 6-minute walk, CT scan, Medical Research Council dyspnea scale (MRC), St. George's Respiratory Questionnaire (SGRQ), COPD Assessment Test (CAT), Pittsburgh Sleep Quality Index (PSQI), CASA-Q, Spirehealth Tag Device
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)
Status: Not yet recruiting
Last Changed: Nov 19, 2020
First Received: Nov 19, 2020
Disease(s): Chronic Obstructive Pulmonary Disease
Intervention(s): CHF6001 1600µg, CHF6001 3200µg, Placebo, Roflumilast
Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)
Status: Recruiting
Last Changed: Mar 03, 2020
First Received: Aug 28, 2019
Disease(s): Chronic Obstructive Pulmonary Disease Severe, Chronic Bronchitis
Intervention(s): Roflumilast, Azithromycin
Locations: University of Alabama, Birmingham, Alabama, United States
University of Arizona, Tucson, Arizona, United States
University of California, Davis Health, Sacramento, California, United States
Denver Health, Denver, Colorado, United States
Northwestern, Chicago, Illinois, United States
... and 28 other locations.
RheOx Registry Study in Europe
Status: Recruiting
Last Changed: Jan 13, 2020
First Received: Dec 02, 2019
Disease(s): Chronic Bronchitis, COPD
Intervention(s): RheOx
Locations: Otto Wagner Spital, Wien, Austria
Pneumologie Thoraxklinik Heidelberg gGmbH University of Heidelberg, Heidelberg, Baden-Württemberg, Germany